IVA News - Candlesense

Inventiva to Participate in Fireside Chat at the Canaccord Genuity 45th Annual Growth Conference

Daix (France), New York City (New York, United States), August 11, 2025 – Inventiva (Euronext Paris and NASDAQ: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focus...

How might the conference presentation affect analyst estimates and price targets? What is the current share ownership structure and any recent insider transactions? What are the competitive dynamics in the MASH therapeutic space and who are the key competitors?

Clinical trials

13 days ago